Association of WBC count and glucose metabolism among Chinese population aged 40 years and over

Diabetes Research and Clinical Practice

Volumn 82, Issue 1, 2008, Pages 132-138

  Tian, Jing Yan ^a   Yang, Yan ^a,b   Cheng, Qi ^a,b   Huang, Hong Er ^c   Li, Rui ^d   Jiang, Guo Xin ^b,e   Liu, Shi You ^c   Li, Xiao Ying ^a   Ning, Guang ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c Baoshan District Center for Disease Control and Prevention   (China)

^d SHANGHAI MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

IFG; IGT; Type 2 diabetes; White blood cell

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; FEMALE; GLUCOSE METABOLISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LEUKOCYTE COUNT; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; SEX DIFFERENCE; SMOKING HABIT; WAIST CIRCUMFERENCE;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; CARBOHYDRATE METABOLISM; CHINA; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; REGRESSION ANALYSIS;

EID: 52949119513     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.05.014     Document Type: Article

References (27)

1. Schmidt M.I., Duncan B.B., Sharrett A.R., Lindberg G., Savage P.J., Offenbacher S., et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 353 (1999) 1649-1652
2. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126
3. Yudkin J.S., Juhan-Vague I., Hawe E., Humphries S.E., di Minno G., Margaglione M., et al. Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. Metabolism 53 (2004) 852-857
4. Retnakaran R., Hanley A.J.G., Connelly P.W., Harris S.B., and Zinman B. Elevated C-reactive protein in Native Canadian children: an ominous early complication of childhood obesity. Diabetes Obes. Metab. 8 (2006) 483-491
5. Festa A., D'Agostino R.B., Tracy R.P., and Haffner S.M. Elevated levels of acute phase proteins and plasminogen activator inhibitor-1 (PAI-1) predict the development of type 2 diabetes mellitus: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes 51 (2002) 1131-1137
6. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342 (2000) 836-843
7. Freeman D.J., Norrie J., Sattar N., Neely R.D., Cobbe S.M., Ford I., et al. Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation 103 (2001) 357-362
8. Lindsay R.S., Krakoff J., Hanson R.L., Bennett P.H., and Knowler W.C. Gamma globulin levels predict type 2 diabetes in the Pima Indian population. Diabetes 50 (2001) 1598-1603
9. Knowler W.C., Pettitt D.J., Saad M.F., and Bennett P.H. Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab. Rev. 6 (1990) 1-27
10. Lee C.D., Folsom A.R., Nieto F.J., Chambless L.E., Shahar E., and Wolfe D.A. White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and white men and women. Am. J. Epidemiol. 154 (2001) 758-764
11. Brown D.W., Giles W.H., and Croft J.B. White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort. J. Clin. Epidemiol. 54 (2001) 316-322
12. Saito I., Folsom A.R., Brancati F.L., Duncan B.B., Chambless L.E., and McGovern P.G. Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Ann. Intern. Med. 133 (2000) 81-91
13. Vozarova B., Weyer C., Lindsay R.S., Pratley R.E., Bogardus C., and Tataranni P.A. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51 (2002) 455-461
14. Nakanishi N., Yoshida H., Matsuo Y., Suzuki K., and Tatara K. White blood-cell count and the risk of impaired fasting glucose or type II diabetes in middle-aged Japanese men. Diabetologia 45 (2002) 42-48
15. Tong P.C., Lee K.F., So W.Y., Ng M.H., Chan W.B., Lo M.K., et al. White blood cell count is associated with macro- and microvascular complications in Chinese patients with type 2 diabetes. Diabetes Care 27 (2004) 216-222
16. Wang Y.Y., Lin S.Y., Liu P.H., Cheung B.M., and Lai W.A. Association between hematological parameters and metabolic syndrome components in a Chinese population. J. Diabetes Complicat. 18 (2004) 322-327
17. Chen L.K., Lin M.H., Chen Z.J., Hwang S.J., and Chiou S.T. Association of insulin resistance and hematologic parameters: study of a middle-aged and elderly Chinese population in Taiwan. J. Chin. Med. Assoc. 69 (2006) 248-253
18. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 27 Suppl. 1 (2004) S5-S14
19. Yuan G., Zhou L., Tang J., Yang Y., Gu W., Li F., et al. Serum CRP levels are equally elevated in newly diagnosed type 2 diabetes and impaired glucose tolerance and related to adiponectin levels and insulin sensitivity. Diabetes Res. Clin. Pract. 72 (2006) 244-250
20. Larsson H., Berglund G., Lindgarde F., and Ahrén B. Comparison of ADA and WHO criteria for diagnosis of diabetes and glucose intolerance (Letter). Diabetologia 41 (1998) 1124-1125
21. Metcalf P.A., and Scragg R.K. Comparison of WHO and ADA criteria for diagnosis of glucose status in adults. Diabetes Res. Clin. Pract. 49 (2000) 169-180
22. DECODA Study Group, International Diabetes Epidemiology Group. Cardiovascular risk profile assessment in glucose-intolerant Asian individuals: an evaluation of the World Health Organization two-step strategy: the DECODA Study (Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Asia). Diabet. Med. 19 (2002) 549-557
23. Ohshita K., Yamane K., Hanafusa M., Mori H., Mito K., Okubo M., et al. Elevated white blood cell count in subjects with impaired glucose tolerance. Diabetes Care 27 (2004) 491-496
24. Tominaga M., Eguchi H., Manaka H., Igarashi K., Kato T., and Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: the Funagata Diabetes Study. Diabetes Care 22 (1999) 920-924
25. DECODE Study Group, European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch. Intern. Med. 161 (2001) 397-404
26. Desai M.Y., Dalal D., Santos R.D., Carvalho J.A., Nasir K., and Blumenthal R.S. Association of body mass index, metabolic syndrome, and leukocyte count. Am. J. Cardiol. 97 (2006) 835-838
27. Lohsoonthorn V., Dhanamun B., and Williams M.A. Prevalence of metabolic syndrome and its relationship to white blood cell count in a population of Thai men and women receiving routine health examinations. Am. J. Hypertens. 19 (2006) 339-345